Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP

Main navigation

  • Home
    • About Us
  • Curriculum
    • Search Courses
  • Knowledge Map
    • Knowledge Map Summary
  • Page Library
    • Content Page Summary
    • Translations
  • Documents

Search

BPaLM: Updates in Management of Dr-TB

  1. Home
  2. BPaLM: Updates in Management of Dr-TB
  3. BPaLM: Updates in Management of Dr-TB
  • Integrated DR-TB Algorithm

    H5Content
  • Eligibility Criteria for BPaLM

    H5Content
  • Relative contraindications Criteria for BPaLM

    H5Content
  • Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Eligibility Criteria

    H5Content
  • Pre-treatment Evaluation [PTE] of DR-TB Patients​

    H5Content
  • TB Disease Severity considerations for Management

    H5Content
  • Treatment initiation for MDR/RR-TB cases

    H5Content
  • Overview of Treatment Course for patients on BPaLM regimen

    H5Content
  • Management of BPaLM ineligible patients

    H5Content
  • Regimen modification for patients on BPaLM regimen

    H5Content
  • Implementation Consideration for BPaLM regimen

    H5Content
  • Extension criterion for BPaLM regimen

    H5Content
  • Screening of patients on BPaLM regimen for Linezolid toxicity

    H5Content
  • Follow-up monitoring of BPaLM

    H5Content
  • Follow-up monitoring of modified shorter oral MDR/RR-TB regimen with Lzd

    H5Content
  • Regimen Modification of Shorter Oral MDR/RR regimen containing Bdq and Lnz

    H5Content
  • Principles of Switching from BpalL/ Shorter Oral Regimen to Longer Oral Regimen

    H5Content
  • Refreshing BDQ course after switching between regimens

    H5Content
Cover

This chapter discusses the details regarding the various updates with respect to BPaLM regimen and other updates regarding the shorter-oral and longer-oral regimen.

User account menu

  • Log in

This work is licensed under Attribution-NonCommercial 4.0 International